Do LSD and Magic Mushrooms Have a Place In Medicine?

97358355
Getty Images

Experts say it’s hard to do research on the drugs under their current status

LSD and magic mushrooms are illegal for recreational use, but some medical experts see major benefits from the drugs. In a commentary published in the journal The BMJ on Tuesday, a London-based psychiatrist argues in favor of legally reclassifying the drugs so that they can more easily be used in medical research.

In his paper, James Rucker, a psychiatrist and honorary lecturer at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, argues that psychedelic drugs like LSD are less harmful and addictive than other controlled drugs like cocaine or heroin. But strict restrictions on the drugs make it difficult to conduct medical trials, he says…..

More research is needed to determine the safety and medical potential of psychedelic drugs —but in the UK, only four hospitals hold the expensive license necessary to conduct research on schedule 1 drugs, Rucker says.

Do LSD and Magic Mushrooms Have a Place In Medicine? | TIME.

Magic mushrooms ‘less harmful than thought’ , says leading psychiatrist

Researchers are beginning to look again at how LSD and psilocybin – the active compound in magic mushrooms – might be of benefit in the treatment of addiction, for obsessive compulsive disorder and even, according to one small Swiss study, to alleviate the symptoms of anxiety in terminally ill patients.

However, writing in the BMJ, psychiatrist Dr James Rucker, said that no evidence had ever shown the drugs to be habit-forming. There is also little evidence of harm when used in controlled settings, and a wealth of studies indicating that they have uses in the treatment of common psychiatric disorders, he said.

 Curated from Magic mushrooms ‘less harmful than thought’ and should be reclassified, says leading psychiatrist – Health News – Health & Families – The Independent

LSD cures depression? Scientists plead for cash to fund ‘exciting’ drug study

The study, carried out as part of a psychedelic research project by neuroscientists at Imperial College London, is expected to “revolutionize” scientists understanding of the brain.

To date, the project has been partially funded by Imperial College London and the Beckley Foundation. However, researchers are now in need of £25,000 to analyze scans.